SMTL ID : 5fd2.1

B-Raf wild-type kinase domain in complex with a purinylpyridinylamino-based inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.89 Å

Oligo State

homo-dimer

Ligands

2 x 5XJ: 6-[2-[[3-(dimethylsulfamoylamino)-2,6-bis(fluoranyl)phenyl]amino]pyridin-3-yl]-7~{H}-purine(Non-covalent)

5XJ.1: 15 residues within 4Å: Chain A: V.45, A.55, K.57, L.79, L.88, I.101, T.103, Q.104, W.105, C.106, F.157, G.167, D.168, F.169, G.170 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.45, A:K.57, A:K.57, A:I.101, A:T.103, A:F.157 Hydrogen bonds: A:T.103, A:T.103, A:C.106, A:D.168, A:F.169, A:G.170 Water bridges: A:K.57, A:K.175 5XJ.2: 15 residues within 4Å: Chain B: V.45, A.55, V.56, K.57, L.88, I.101, T.103, Q.104, W.105, C.106, F.157, G.167, D.168, F.169, G.170 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:K.57, B:F.157 Hydrogen bonds: B:C.106, B:D.168, B:F.169, B:G.170 pi-Stacking: B:W.105, B:F.157, B:F.157

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, L. et al., Purinylpyridinylamino-based DFG-in/ alpha C-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling. Bioorg.Med.Chem. (2016)

Release Date

2016-05-04

Peptides

Serine/threonine-protein kinase B-raf: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Serine/threonine-protein kinase B-raf